The AMPER Study: Evaluation of the Efficacy of Human Amniotic Membrane Grafting in Preventing Mesh Exposure in Vaginal Reconstructive Surgery Using Polypropylene Mesh.
Recruiting now · Not applicable
Conditions studied: Pelvic Organ Prolapse Vaginal Surgery, Stress Urinary Incontinence in Women
In brief
This study evaluates the efficacy of adding a human amniotic membrane graft to polypropylene mesh surgery for pelvic prolapse and stress urinary incontinence. The goal is to assess improvements in tissue integration and the reduction of surgical complications
Key facts
- Study ID
- NCT07414849
- Run by
- Hospital General de Agudos J. M. Penna
- People needed
- 330
- Starts
- 2026-03-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-06-17
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Pelvic organ prolapse (POP) stage II C or greater, defined as C ≥ +1, in women without prior hysterectomy and/or with a diagnosis of stress urinary incontinence seeking surgical treatment.
- Ability to understand study information and provide written informed consent.
- Availability for follow-up for a minimum of 12 months.
You may not qualify if…
- Previous surgery with synthetic mesh (via vaginal or abdominal approach) for POP repair.
- Known adverse reaction to synthetic meshes.
- Unresolved or active chronic pelvic pain.
- History of prior abdominal or pelvic radiation.
- Contraindication to the planned surgical procedure.
- Current pregnancy.
Where it is running
- Hospital J M Penna — Buenos Aires, Argentina (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.